C7orf25

gene
On this page

Also known as MGC2821

Summary

C7orf25 (chromosome 7 open reading frame 25, HGNC:21703) is a protein-coding gene on chromosome 7p14.1, encoding UPF0415 protein C7orf25 (Q9BPX7).

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 10 total — 1 pathogenic
  • MANE Select transcript: NM_001099858

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21703
Approved symbolC7orf25
Namechromosome 7 open reading frame 25
Location7p14.1
Locus typegene with protein product
StatusApproved
AliasesMGC2821
Ensembl geneENSG00000136197
Ensembl biotypeprotein_coding
Entrez79020

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 9 protein_coding

ENST00000350427, ENST00000425683, ENST00000432637, ENST00000438029, ENST00000447342, ENST00000882403, ENST00000932826, ENST00000932827, ENST00000962379

RefSeq mRNA: 3 — MANE Select: NM_001099858 NM_001099858, NM_001363436, NM_024054

CCDS: CCDS5466

Canonical transcript exons

ENST00000350427 — 2 exons

ExonStartEnd
ENSE000018933944291191542912070
ENSE000027221814290927342910921

Expression profiles

Bgee: expression breadth ubiquitous, 132 present calls, max score 86.78.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.6823 / max 88.6392, expressed in 1589 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
837903.68231589

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.78gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.10gold quality
monocyteCL:000057675.22gold quality
corpus callosumUBERON:000233674.94gold quality
leukocyteCL:000073874.67gold quality
Brodmann (1909) area 9UBERON:001354072.78gold quality
C1 segment of cervical spinal cordUBERON:000646972.44gold quality
islet of LangerhansUBERON:000000672.30gold quality
dorsolateral prefrontal cortexUBERON:000983471.95gold quality
right adrenal gland cortexUBERON:003582771.49gold quality
substantia nigraUBERON:000203871.26gold quality
calcaneal tendonUBERON:000370170.99gold quality
descending thoracic aortaUBERON:000234570.76gold quality
hypothalamusUBERON:000189870.62gold quality
endometriumUBERON:000129570.51gold quality
anterior cingulate cortexUBERON:000983570.16gold quality
cerebral cortexUBERON:000095670.03gold quality
Ammon’s hornUBERON:000195470.03gold quality
amygdalaUBERON:000187669.96gold quality
muscle of legUBERON:000138369.82gold quality
left adrenal glandUBERON:000123469.74gold quality
right adrenal glandUBERON:000123369.73gold quality
gastrocnemiusUBERON:000138869.68gold quality
stromal cell of endometriumCL:000225569.55gold quality
right frontal lobeUBERON:000281069.52gold quality
smooth muscle tissueUBERON:000113569.44gold quality
thoracic aortaUBERON:000151569.33gold quality
temporal lobeUBERON:000187169.33gold quality
popliteal arteryUBERON:000225069.26gold quality
tibial arteryUBERON:000761069.25gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.13

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

37 targeting C7orf25, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-25-3P99.9874.601817
HSA-MIR-32-5P99.9875.211964
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-218-5P99.9372.222103
HSA-MIR-515-5P99.9269.822343
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-629-3P99.8567.991875
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-30B-3P99.7065.762325
HSA-MIR-3689A-3P99.7065.732306
HSA-MIR-3689B-3P99.7065.712311
HSA-MIR-3689C99.7065.712311
HSA-MIR-6779-5P99.7065.762363
HSA-MIR-1260A99.6166.671098
HSA-MIR-1260B99.6166.671098
HSA-MIR-432899.5771.064094
HSA-MIR-766-3P99.4765.241811
HSA-MIR-132499.4666.571302
HSA-MIR-2116-5P99.3269.341273
HSA-MIR-1273H-3P99.2967.55980
HSA-MIR-488-5P99.2868.12821
HSA-MIR-397399.2069.191990
HSA-MIR-6799-5P99.1465.722093
HSA-MIR-154-5P98.9266.65733
HSA-MIR-29B-1-5P98.8668.351364

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioC2H7orf25ENSDARG00000057184
mus_musculusAW209491ENSMUSG00000039182
rattus_norvegicusC17h7orf25ENSRNOG00000015523
drosophila_melanogasterCG42553FBGN0260755
caenorhabditis_elegansWBGENE00018015

Protein

Protein identifiers

UPF0415 protein C7orf25Q9BPX7 (reviewed: Q9BPX7)

All UniProt accessions (3): C9JF90, C9K0L6, Q9BPX7

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the UPF0415 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9BPX7-11yes
Q9BPX7-22

RefSeq proteins (3): NP_001093328, NP_001350365, NP_076959 (=MANE)

Domains & families (InterPro)

IDNameType
IPR010733DUF1308Domain
IPR041076DUF5614Domain

Pfam: PF07000, PF18474

UniProt features (4 total): chain 1, splice variant 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BPX7-F189.570.79

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 67 (showing top): BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, TATCTGG_MIR488, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, ACEVEDO_LIVER_CANCER_UP, DURCHDEWALD_SKIN_CARCINOGENESIS_UP, KIM_WT1_TARGETS_DN, WILCOX_RESPONSE_TO_PROGESTERONE_UP, MIKKELSEN_ES_ICP_WITH_H3K4ME3, CHANGOLKAR_H2AFY_TARGETS_DN, KRIEG_KDM3A_TARGETS_NOT_HYPOXIA, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN, CIITA_TARGET_GENES, RBM34_TARGET_GENES, SFMBT1_TARGET_GENES, SKIL_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1

Protein interactions and networks

STRING

306 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C7orf25CXorf58Q96LI9666
C7orf25SMLR1H3BR10580
C7orf25PSMA2P25787539
C7orf25VOPP1Q96AW1496
C7orf25SEC61GP38384490
C7orf25FAM204AQ9H8W3477
C7orf25BLVRAP53004433
C7orf25ZSCAN2Q7Z7L9419
C7orf25LANCL2Q9NS86413
C7orf25FAM220AQ7Z4H9412
C7orf25STK17AQ9UEE5408
C7orf25ANKRD40Q6AI12400
C7orf25RSRP1Q9BUV0397
C7orf25MRPL54Q6P161378
C7orf25SMAGPQ0VAQ4378

IntAct

32 interactions, top by confidence:

ABTypeScore
C7orf25psi-mi:“MI:0915”(physical association)0.560
TARS1C7orf25psi-mi:“MI:0915”(physical association)0.560
C7orf25psi-mi:“MI:0915”(physical association)0.560
GTPBP1C7orf25psi-mi:“MI:0915”(physical association)0.560
RANBP2C7orf25psi-mi:“MI:0407”(direct interaction)0.540
C7orf25RANBP2psi-mi:“MI:0915”(physical association)0.540
C7orf25MUC5Bpsi-mi:“MI:0915”(physical association)0.400
C7orf25CEP70psi-mi:“MI:0915”(physical association)0.370
C7orf25CRYMpsi-mi:“MI:0915”(physical association)0.370
C7orf25DACT1psi-mi:“MI:0915”(physical association)0.370
EZH2C7orf25psi-mi:“MI:0915”(physical association)0.370
C7orf25MTORpsi-mi:“MI:0915”(physical association)0.370
C7orf25FYNpsi-mi:“MI:0915”(physical association)0.370
C7orf25HAP1psi-mi:“MI:0915”(physical association)0.370
C7orf25NGEFpsi-mi:“MI:0915”(physical association)0.370
PTNC7orf25psi-mi:“MI:0915”(physical association)0.370
RASSF1C7orf25psi-mi:“MI:0915”(physical association)0.370
RPL36ALC7orf25psi-mi:“MI:0915”(physical association)0.370
SF3B2C7orf25psi-mi:“MI:0915”(physical association)0.370
C7orf25UBE2D1psi-mi:“MI:0915”(physical association)0.370
GTPBP1C7orf25psi-mi:“MI:0915”(physical association)0.000
FRA10AC1C7orf25psi-mi:“MI:0915”(physical association)0.000
HEXDC7orf25psi-mi:“MI:0915”(physical association)0.000
TUBB2AC7orf25psi-mi:“MI:0915”(physical association)0.000
BRD4C7orf25psi-mi:“MI:0915”(physical association)0.000

BioGRID (24): C7orf25 (Two-hybrid), MYH14 (Affinity Capture-MS), MUC5B (Affinity Capture-MS), C7orf25 (Two-hybrid), MUC5B (Affinity Capture-MS), C7orf25 (Affinity Capture-MS), C7orf25 (Two-hybrid), C7orf25 (Two-hybrid), C7orf25 (Two-hybrid), C7orf25 (Two-hybrid), C7orf25 (Cross-Linking-MS (XL-MS)), FYN (Two-hybrid), CEP70 (Two-hybrid), RPL36AL (Two-hybrid), CRYM (Two-hybrid)

ESM2 similar proteins: A0A0M5K865, A0A2H5RJD4, A0JND4, A4RKC3, A8N5E5, A8NS89, B0D0N9, B4IB36, B4QL99, B6K0N7, E9M7A1, F4IF36, F4JPP0, G4YRT1, G4YUT3, P06623, P09543, P0CV73, P93042, Q0E0Q3, Q0JLS6, Q0UI93, Q1LZE8, Q2H0G2, Q2M3Z7, Q2M3Z8, Q2M405, Q2M408, Q2QMH2, Q2R224, Q2VF19, Q43827, Q5M888, Q5RFD0, Q5RFL4, Q6FLD4, Q75EG6, Q7S8J7, Q803H0, Q810J8

Diamond homologs: Q08AW5, Q1LZE8, Q5BKL1, Q5M888, Q803H0, Q91WD4, Q9BPX7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

10 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance8
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
59681GRCh38/hg38 7p14.1-13(chr7:42388724-43606751)x3Pathogenic

SpliceAI

498 predictions. Top by Δscore:

VariantEffectΔscore
7:42912060:T:TAdonor_gain1.0000
7:42910917:CTTTC:Cacceptor_gain0.9900
7:42910922:C:CCacceptor_gain0.9900
7:42910923:T:Aacceptor_loss0.9900
7:42910920:TCCTA:Tacceptor_loss0.9800
7:42910921:CCTAG:Cacceptor_loss0.9800
7:42910922:CTAGG:Cacceptor_loss0.9800
7:42912066:A:ACdonor_gain0.9700
7:42912028:C:CTdonor_gain0.9600
7:42910919:TTC:Tacceptor_gain0.9500
7:42910920:TC:Tacceptor_gain0.9500
7:42910921:CC:Cacceptor_gain0.9500
7:42912027:TC:Tdonor_gain0.9500
7:42912061:C:Adonor_gain0.9500
7:42911015:G:Cdonor_gain0.9400
7:42911467:CG:Cdonor_gain0.9400
7:42911487:G:GAdonor_gain0.9400
7:42911541:C:CTdonor_gain0.9400
7:42911914:CCGG:Cdonor_gain0.9400
7:42910918:TTTC:Tacceptor_gain0.9300
7:42911076:T:TAdonor_gain0.9300
7:42911466:A:ACdonor_gain0.9300
7:42911467:C:CCdonor_gain0.9300
7:42912029:C:CTdonor_gain0.9300
7:42911460:GTACT:Gdonor_loss0.9200
7:42911461:TACTT:Tdonor_loss0.9200
7:42911462:ACT:Adonor_loss0.9200
7:42911463:CTT:Cdonor_loss0.9200
7:42911464:TTA:Tdonor_loss0.9200
7:42911465:TA:Tdonor_loss0.9200

AlphaMissense

2763 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:42909702:A:TL400H1.000
7:42909777:G:TA375D1.000
7:42909815:A:CF362L1.000
7:42909815:A:TF362L1.000
7:42909817:A:GF362L1.000
7:42910555:A:GW116R1.000
7:42910555:A:TW116R1.000
7:42910695:A:GL69P1.000
7:42910757:G:CF48L1.000
7:42910757:G:TF48L1.000
7:42910759:A:GF48L1.000
7:42909689:T:AK404N0.999
7:42909689:T:GK404N0.999
7:42909702:A:GL400P0.999
7:42909705:G:TA399E0.999
7:42909707:T:AR398S0.999
7:42909707:T:GR398S0.999
7:42909708:C:GR398T0.999
7:42909718:G:CH395D0.999
7:42909753:G:TA383E0.999
7:42909754:C:GA383P0.999
7:42909757:C:GA382P0.999
7:42909759:C:GR381T0.999
7:42909762:A:TV380D0.999
7:42909764:A:CF379L0.999
7:42909764:A:TF379L0.999
7:42909765:A:GF379S0.999
7:42909766:A:GF379L0.999
7:42909773:A:CN376K0.999
7:42909773:A:TN376K0.999

dbSNP variants (sampled 300 via entrez): RS1000335453 (7:42913264 C>T), RS1000430279 (7:42912952 T>C), RS1000736839 (7:42909254 A>C,G), RS1002588763 (7:42912496 G>C), RS1002708766 (7:42911428 C>A,T), RS1003393016 (7:42909903 C>A,T), RS1003401187 (7:42911602 C>T), RS1003697016 (7:42911239 T>G), RS1003954407 (7:42911799 GC>G), RS1004658309 (7:42912450 G>A), RS1004779869 (7:42912229 T>A,C), RS1005218368 (7:42909125 A>G), RS1005499428 (7:42909331 G>A), RS1006402489 (7:42909982 CA>C), RS1007169361 (7:42913393 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST005212_23Asthma4.000000e-06
GCST010121_7Ceramide levels (C24:0)3.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

18 total (human), top 18 by PubMed support.

ChemicalActions (top 5)PubMed papers
methylmercuric chloridedecreases expression1
salinomycindecreases expression1
manganese chlorideincreases abundance, increases expression1
jinfukangincreases expression1
Sunitinibincreases expression1
Air Pollutantsincreases abundance, increases expression1
Atrazinedecreases expression1
Coalincreases abundance, increases expression1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Formaldehydedecreases expression1
Manganeseincreases abundance, increases expression1
Seleniumdecreases expression1
Smokeincreases abundance, increases expression1
Urethanedecreases expression1
Valproic Acidaffects expression1
Antirheumatic Agentsincreases expression1
Copper Sulfatedecreases expression1
S-Nitrosoglutathioneaffects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.